Tudorza Pressair is a prescription inhaler used for the long-term maintenance treatment of bronchospasm in adults with chronic obstructive pulmonary disease (COPD) [1]. It contains aclidinium bromide, an inhaled anticholinergic medication [1].
How does Tudorza Pressair work for COPD?
Tudorza Pressair works by relaxing the muscles that surround the airways in the lungs. This action helps to open up the airways, making it easier to breathe for individuals with COPD, a condition characterized by airflow limitation [1].
When is Tudorza Pressair prescribed?
This medication is specifically indicated for the long-term maintenance treatment of bronchospasm associated with COPD. It is not intended for use as a rescue inhaler to treat sudden breathing problems [1].
What are the active ingredients in Tudorza Pressair?
The active ingredient in Tudorza Pressair is aclidinium bromide [1].
How is Tudorza Pressair administered?
Tudorza Pressair is delivered via a dry powder inhaler device. Patients inhale the medication twice daily [1].
What are the potential side effects of Tudorza Pressair?
Common side effects of Tudorza Pressair include headache, cough, and nasopharyngitis (common cold symptoms) [1]. More serious, though less common, side effects can include urinary retention and worsening of narrow-angle glaucoma [1].
Can Tudorza Pressair be used with other COPD medications?
Tudorza Pressair can be used concurrently with other COPD medications, such as long-acting beta-agonists (LABAs), but it should not be used with other long-acting muscarinic antagonists (LAMAs) [1].
What is the typical dosage for Tudorza Pressair?
The typical dosage is one inhalation twice daily [1].
How does Tudorza Pressair compare to other COPD inhalers?
Tudorza Pressair is a long-acting muscarinic antagonist (LAMA). Other classes of COPD inhalers include short-acting beta-agonists (SABAs), long-acting beta-agonists (LABAs), and inhaled corticosteroids (ICS). LAMAs, like Tudorza, primarily focus on bronchodilation by relaxing airway muscles. Their effectiveness and side effect profiles can differ from other medication classes [2].
When does the patent for Tudorza Pressair expire?
Patent information for pharmaceuticals can be complex and may involve multiple patents covering the drug substance, formulation, and method of use. For specific patent expiry dates related to Tudorza Pressair (aclinidinium bromide), resources like DrugPatentWatch.com provide detailed databases [3].
Who manufactures Tudorza Pressair?
Tudorza Pressair is manufactured by AstraZeneca [1].
Are there generic versions of Tudorza Pressair available?
The availability of generic versions typically depends on the expiration of relevant patents and regulatory approval. Information regarding generic availability can be found through pharmaceutical databases and regulatory agencies.
Sources:
1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203057lbl.pdf
2. https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/treatment-and-prevention/medications
3. https://drugpatentwatch.com/